RENVA covers home labs telehealth providers with independent pricing research and comparison guides. All affiliate relationships are disclosed. No medical advice.
Order-to-results pipeline, sample types, CLIA lab processing, and instant self-tests vs mail-in kits.
What CLIA regulates, waived vs higher-complexity testing, CAP accreditation, and accuracy limits.
Capillary vs venous concordance, hemolysis risks, and when an in-office draw is still preferable.
State variation in direct-access testing, partner-physician ordering, and abnormal-result follow-up.
Urgent vs routine next steps, why confirmation matters, and why home results are not prescriptions.
Self-test vs self-collection, which infections fit home pathways, and timing after exposure.
What IgG panels measure — and why AAAAI recommends against using them for allergy or intolerance diagnosis.
TSH, free T4/T3, and antibodies — what abnormal results mean and USPSTF screening limits.
LDL, HDL, triglycerides, and total cholesterol — risk context, fasting, and home vs office testing.
16S/metagenomics kits, scarce clinical usefulness, and DTC lab variability across companies.
2–3 month average glucose, CDC diagnostic thresholds, confirmation rules, and capillary concordance.
cfDNA methylation signals, non–FDA-approved LDT status, and why MCED must not replace proven screenings.
Diurnal cortisol rhythm, limits of single-point stress panels, and Endocrine Society Cushing guidance.
Screening and monitoring vs diagnosis — when kits help and when clinic care is required.
Sample quality tradeoffs across capillary, venous, and swab/urine collection for common kits.
CLIA lab disclosure, CAP accreditation, physician review, and red flags before you enroll.
Pre-purchase checklist: lab partner, review model, turnaround, redraws, and intended use.
FDA clearance of the test system vs CLIA certification of the lab — and what LDTs mean for consumers.
Cost drivers — single test vs panel vs membership, collection method, review fees — with live hub pricing.
Wellness baselines vs symptom-driven vs monitoring cadences — and why subscriptions are not guidelines.
Affiliate disclosure: RENVA may earn affiliate commissions from some provider links. Affiliate relationships do not influence provider scoring or editorial conclusions. Full disclosure →
Medical disclaimer: RENVA is not a healthcare provider. Content is informational and educational only. Always consult a licensed healthcare professional before making health decisions. Full disclaimer →